New Research Shows Significant Benefits for COPD Patients in the Home Using Fisher & Paykel Healthcare's myAirvo |
| April 20, 2018 | April 2018 Bond Updates |
|
AUCKLAND, New Zealand, April 20, 2018 /PRNewswire/ -- Fisher & Paykel Healthcare Corporation Limited announced today that new research has been published in the International Journal of COPD which demonstrates significant benefits of nasal high flow therapy for COPD* patients using... |
| View more at: https://www.prnewswire.com/news-releases/new-research-shows-significant-benefits-for-copd-patients-in-the-home-using-fisher--paykel-healthcares-myairvo-300633563.html |
| Related News |